Search results
Regeneron's (REGN) Dupixent Meets Pivotal COPD Study Goal, Up 7%
Zacks via Yahoo Finance· 1 year agoRegeneron's (REGN) share price rose after it reported data from a late-stage study showing that...
AstraZeneca's (AZN) Asthma Drug Tezepelumab Gets Nod in Europe
Zacks via Yahoo Finance· 2 years agoAstraZeneca's (AZN) Tezspire is the only biologic medicine approved in Europe to treat severe asthma...
GSK's Key Drugs to Drive Sales in a Sluggish Second Half
Zacks via Yahoo Finance· 2 years agoGSK's specialty products like Dovato, Nucala, Trelegy Ellipta, Shingrix are driving sales, making up...
GSK's New Drugs and Pipeline Hold the Key to Growth in 2023
Zacks via Yahoo Finance· 1 year agoGSK's specialty products like Dovato, Nucala, Trelegy Ellipta and Shingrix are likely to drive...
GSK Gears Up to Report Q1 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 1 year agoGSK plc. GSK will report first-quarter 2023 results on Apr 26, before the opening bell. In the last...
Zacks Industry Outlook Highlights Gilead Sciences, GSK, Immunocore and Syndax Pharmaceuticals
Zacks via Yahoo Finance· 1 year agoFor Immediate Release Chicago, IL – December 28, 2022 – Today, Zacks Equity Research discusses...
GSK Gears Up for Q1 Earnings: Here's What to Expect
Zacks via Yahoo Finance· 2 weeks agoWe expect GSK's specialty products like Arexvy, Cabenuva, Juluca, Dovato, Nucala, Trelegy Ellipta and Shingrix to drive first-quarter sales performance.
3 Big Drug, Biotech Stocks to Boost Your Portfolio in 2023
Zacks via Yahoo Finance· 1 year agoHere we discuss three big drug and biotech companies, Sanofi (SNY), GSK (GSK) and BioNTech (BNTX),...
Pharma Stock Roundup: FDA Nod to Updated PFE, MRNA COVID Jabs, & More
Zacks via Yahoo Finance· 8 months agoThe FDA authorizes Pfizer (PFE) and Moderna's (MRNA) updated mRNA-based COVID-19 vaccines. Novo...
20 Fastest Growing Health Tech Companies in the World
Insider Monkey via Yahoo Finance· 1 week agoIn this article, we will be taking a look at the 20 fastest growing health tech companies in the...